Research in animal models has shown significant reductions in body weight and adipose tissue, with studies reporting up to 50% less weight gain in obese Zucker rats after 19 days of administration
Helps visibly improve skin firmness and elasticity
Originally distributed for the treatment of type 2 diabetes, GLP-1 medications have since been used on a widespread level for addressing obesity and helping patients achieve their weight loss goals
The optimal timing for semaglutide administration differs significantly between the injectable and oral formulations, and following manufacturer guidelines is essential for achieving maximum therapeutic effect
Cost effective: Unlike complex electronic monitoring systems such as data loggers, Timestrip indicators are affordable and scalable, making them suitable for widespread deployment
The recent approval of the oral Wegovy pill, effective from December 2023, offers an alternative for those who prefer not to inject